Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEPsychopharmacology — lithium

Psych CASC / OSCE · Psychopharmacology — lithium

Explaining lithium monitoring and suicide benefit to a patient (CASC)

CASC-style communication station: shared decision on lithium vs valproate defaults, monitoring plan, interaction/sick-day rules, anti-suicide evidence, and balanced organ and pregnancy risk framing.

communication2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 31-year-old man with bipolar I disorder and a recent serious suicide attempt is offered lithium for maintenance. He fears 'kidney failure and birth defects if I ever have kids' and prefers 'just valproate like my cousin'.

Station instructions (candidate)

You have 7 minutes. Explain why lithium is being offered after a manic episode and serious suicide attempt, what blood monitoring means in plain language (levels plus kidney, thyroid and calcium), how everyday medicines like ibuprofen can raise levels, and which symptoms need urgent review. Balance organ and future-pregnancy concerns against relapse prevention and anti-suicide evidence. Do not guarantee cure. Do not dismiss fears. Do not invent exact national laboratory cut-offs as universal rules — explain principles and local protocols.[1][2][3]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet, 2010.PMID 20092882
  2. [2]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104
  3. [3]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
  4. [4]Patorno E, Huybrechts KF, Bateman BT, et al. Lithium Use in Pregnancy and the Risk of Cardiac Malformations N Engl J Med, 2017.PMID 28591541
  5. [5]Gitlin M Lithium side effects and toxicity: prevalence and management strategies Int J Bipolar Disord, 2016.PMID 27900734
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining lamotrigine titration and rash safety (CASC)Psychopharmacology — lamotrigineNextExplaining lithium versus valproate and pregnancy-safe planning (CASC)Psychopharmacology — mood stabilisers